Citalopram vs Pembrolizumab
Citalopram vs Pembrolizumab: Overview
This comparison examines the pharmacological differences between Citalopram and Pembrolizumab.
Mechanism of Action
Citalopram: Selective serotonin reuptake inhibitor (SSRI); racemic mixture with escitalopram as active S-enantiomer.
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Citalopram — 35 hours; Pembrolizumab — 26 days.
Chemical Properties
Molecular Formula: Citalopram — C20H21FN2O.
Molecular Weight: Citalopram — 324.3920 g/mol.
Type: Citalopram — Small molecule; Pembrolizumab — Antibody.